Molecular Medicine BioServices Overview

  • Founded
  • 1997
  • Status
  • Acquired/​Merged
  • Employees
  • 60
  • Latest Deal Type
  • M&A

Molecular Medicine BioServices General Information


Provider of contract manufacturing and clinical services to clients in the viral, cell therapy and vaccine sectors of the bio pharmaceutical industry. The company assist clients in initiating clinical trials by producing their viral vectors, master cell and viral banks, and through performing ex-vivo cell manipulations. The company provides process development and clinical manufacturing for academic, industrial, and government clients, both in the U.S. and abroad.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Pharmaceuticals and Biotechnology
Primary Office
  • 1890 Rutherford Road
  • Suite 200
  • Carlsbad, CA 92008
  • United States
+1 (760) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Molecular Medicine BioServices Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Merger/Acquisition 08-May-2007 00.000 Completed Generating Revenue
4. Later Stage VC (Series C) 25-Oct-2005 00.000 00.000 Completed Generating Revenue
3. Later Stage VC (Series C) 07-May-2004 00000 00.000 Completed Generating Revenue
2. Early Stage VC (Series B) 25-Sep-2003 $3M $3.4M Completed Generating Revenue
1. Early Stage VC (Series A) 23-Jul-2002 $405K $405K Completed Product Development
To view Molecular Medicine BioServices’s complete valuation and funding history, request access »

Molecular Medicine BioServices Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Molecular Medicine BioServices Former Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Corporate Opportunities Fund Other Minority 000 0000 000000 0
DM Biologics Corporation Minority 000 0000 000000 0
Edelman Financial Services Asset Manager Minority 000 0000 000000 0
Phase 3 Real Estate Partners Corporation Majority 000 0000 000000 0
Signet Healthcare Partners Growth/Expansion Minority 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »